Abstract
Background
Previous studies have shown that the gut microbiota plays an important role in the maintenance of thyroid homeostasis. We aimed to evaluate the causal relationships between gut microbiota and hypothyroidism.
Methods
Summary statistics for 211 gut microbiota taxa were obtained from the largest available genome-wide association study (GWAS) meta-analysis conducted by the MiBioGen consortium. Summary statistics for hypothyroidism were obtained from two distinct sources: the FinnGen consortium R9 release data (40,926 cases and 274,069 controls) and the UK Biobank data (22,687 cases and 440,246 controls), respectively. A two-sample Mendelian randomization (MR) design was employed, and thorough sensitivity analyses were carried out to ensure the reliability of the results.
Results
Based on the FinnGen consortium, we found increased levels of Intestinimonas (OR = 1.09; 95%CI = 1.02–1.16; P = 0.01) and Ruminiclostridium5 (OR = 1.11; 95%CI = 1.02–1.22; P = 0.02) may be associated with a higher risk of hypothyroidism, while increased levels of Butyrivibrio (OR = 0.95; 95%CI = 0.92–0.99; P = 0.02), Eggerthella (OR = 0.93; 95%CI = 0.88–0.98; P = 0.01), Lachnospiraceae UCG008 (OR = 0.92; 95%CI = 0.85–0.99; P = 0.02), Ruminococcaceae UCG011 (OR = 0.95; 95%CI = 0.90–0.99; P = 0.02), and Actinobacteria (OR = 0.88; 95%CI = 0.80–0.97; P = 0.01) may be associated with a lower risk. According to the UK Biobank data, Eggerthella and Ruminiclostridium5 remain causally associated with hypothyroidism. The sensitivity analysis demonstrates consistent results without evidence of heterogeneity or pleiotropy.
Conclusion
This study highlights the impact of specific gut microbiota on hypothyroidism. Strategies to change composition of gut microbiota may hold promise as potential interventions.
Similar content being viewed by others
Data availability
The data for this study were sourced from publicly available archives and former investigative studies.
References
H. Brody, The gut microbiome. Nature 577(7792), S5 (2020). https://doi.org/10.1038/d41586-020-00194-2
Knezevic J., Starchl C., Tmava Berisha A., Amrein K. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients 12(6) (2020). https://doi.org/10.3390/nu12061769
W. Jiang, G. Lu, D. Gao, Z. Lv, D. Li, The relationships between the gut microbiota and its metabolites with thyroid diseases. Front. Endocrinol. 13, 943408 (2022). https://doi.org/10.3389/fendo.2022.943408
C. Virili, I. Stramazzo, M. Centanni, Gut microbiome and thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab. 35(3), 101506 (2021). https://doi.org/10.1016/j.beem.2021.101506
Sawicka-Gutaj N., Gruszczyński D., Zawalna N., Nijakowski K., Muller I., Karpiński T., Salvi M., Ruchała M. Microbiota alterations in patients with autoimmune thyroid diseases: a systematic review. Int. J. Mol. Sci. 23(21) (2022). https://doi.org/10.3390/ijms232113450
J. Bowden, M.V. Holmes, Meta-analysis and Mendelian randomization: a review. Res. Synth. Methods 10(4), 486–496 (2019). https://doi.org/10.1002/jrsm.1346
V.W. Skrivankova, R.C. Richmond, B.A.R. Woolf, J. Yarmolinsky, N.M. Davies, S.A. Swanson, T.J. VanderWeele, J.P.T. Higgins, N.J. Timpson, N. Dimou, C. Langenberg, R.M. Golub, E.W. Loder, V. Gallo, A. Tybjaerg-Hansen, G. Davey Smith, M. Egger, J.B. Richards, Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326(16), 1614–1621 (2021). https://doi.org/10.1001/jama.2021.18236
A. Kurilshikov, C. Medina-Gomez, R. Bacigalupe, D. Radjabzadeh, J. Wang, A. Demirkan, C.I. Le Roy, J.A. Raygoza Garay, C.T. Finnicum, X. Liu, D.V. Zhernakova, M.J. Bonder, T.H. Hansen, F. Frost, M.C. Rühlemann, W. Turpin, J.Y. Moon, H.N. Kim, K. Lüll, E. Barkan, S.A. Shah, M. Fornage, J. Szopinska-Tokov, Z.D. Wallen, D. Borisevich, L. Agreus, A. Andreasson, C. Bang, L. Bedrani, J.T. Bell, H. Bisgaard, M. Boehnke, D.I. Boomsma, R.D. Burk, A. Claringbould, K. Croitoru, G.E. Davies, C.M. van Duijn, L. Duijts, G. Falony, J. Fu, A. van der Graaf, T. Hansen, G. Homuth, D.A. Hughes, R.G. Ijzerman, M.A. Jackson, V.W.V. Jaddoe, M. Joossens, T. Jørgensen, D. Keszthelyi, R. Knight, M. Laakso, M. Laudes, L.J. Launer, W. Lieb, A.J. Lusis, A.A.M. Masclee, H.A. Moll, Z. Mujagic, Q. Qibin, D. Rothschild, H. Shin, S.J. Sørensen, C.J. Steves, J. Thorsen, N.J. Timpson, R.Y. Tito, S. Vieira-Silva, U. Völker, H. Völzke, U. Võsa, K.H. Wade, S. Walter, K. Watanabe, S. Weiss, F.U. Weiss, O. Weissbrod, H.J. Westra, G. Willemsen, H. Payami, D. Jonkers, A. Arias Vasquez, E.J.C. de Geus, K.A. Meyer, J. Stokholm, E. Segal, E. Org, C. Wijmenga, H.L. Kim, R.C. Kaplan, T.D. Spector, A.G. Uitterlinden, F. Rivadeneira, A. Franke, M.M. Lerch, L. Franke, S. Sanna, M. D’Amato, O. Pedersen, A.D. Paterson, R. Kraaij, J. Raes, A. Zhernakova, Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53(2), 156–165 (2021). https://doi.org/10.1038/s41588-020-00763-1
M.I. Kurki, J. Karjalainen, P. Palta, T.P. Sipilä, K. Kristiansson, K.M. Donner, M.P. Reeve, H. Laivuori, M. Aavikko, M.A. Kaunisto, A. Loukola, E. Lahtela, H. Mattsson, P. Laiho, P. Della Briotta Parolo, A.A. Lehisto, M. Kanai, N. Mars, J. Rämö, T. Kiiskinen, H.O. Heyne, K. Veerapen, S. Rüeger, S. Lemmelä, W. Zhou, S. Ruotsalainen, K. Pärn, T. Hiekkalinna, S. Koskelainen, T. Paajanen, V. Llorens, J. Gracia-Tabuenca, H. Siirtola, K. Reis, A.G. Elnahas, B. Sun, C.N. Foley, K. Aalto-Setälä, K. Alasoo, M. Arvas, K. Auro, S. Biswas, A. Bizaki-Vallaskangas, O. Carpen, C.Y. Chen, O.A. Dada, Z. Ding, M.G. Ehm, K. Eklund, M. Färkkilä, H. Finucane, A. Ganna, A. Ghazal, R.R. Graham, E.M. Green, A. Hakanen, M. Hautalahti, Å.K. Hedman, M. Hiltunen, R. Hinttala, I. Hovatta, X. Hu, A. Huertas-Vazquez, L. Huilaja, J. Hunkapiller, H. Jacob, J.N. Jensen, H. Joensuu, S. John, V. Julkunen, M. Jung, J. Junttila, K. Kaarniranta, M. Kähönen, R. Kajanne, L. Kallio, R. Kälviäinen, J. Kaprio, N. Kerimov, J. Kettunen, E. Kilpeläinen, T. Kilpi, K. Klinger, V.M. Kosma, T. Kuopio, V. Kurra, T. Laisk, J. Laukkanen, N. Lawless, A. Liu, S. Longerich, R. Mägi, J. Mäkelä, A. Mäkitie, A. Malarstig, A. Mannermaa, J. Maranville, A. Matakidou, T. Meretoja, S.V. Mozaffari, M.E.K. Niemi, M. Niemi, T. Niiranen, O.D. CJ, M.E. Obeidat, G. Okafo, H.M. Ollila, A. Palomäki, T. Palotie, J. Partanen, D.S. Paul, M. Pelkonen, R.K. Pendergrass, S. Petrovski, A. Pitkäranta, A. Platt, D. Pulford, E. Punkka, P. Pussinen, N. Raghavan, F. Rahimov, D. Rajpal, N.A. Renaud, B. Riley-Gillis, R. Rodosthenous, E. Saarentaus, A. Salminen, E. Salminen, V. Salomaa, J. Schleutker, R. Serpi, H.Y. Shen, R. Siegel, K. Silander, S. Siltanen, S. Soini, H. Soininen, J.H. Sul, I. Tachmazidou, K. Tasanen, P. Tienari, S. Toppila-Salmi, T. Tukiainen, T. Tuomi, J.A. Turunen, J.C. Ulirsch, F. Vaura, P. Virolainen, J. Waring, D. Waterworth, R. Yang, M. Nelis, A. Reigo, A. Metspalu, L. Milani, T. Esko, C. Fox, A.S. Havulinna, M. Perola, S. Ripatti, A. Jalanko, T. Laitinen, T.P. Mäkelä, R. Plenge, M. McCarthy, H. Runz, M.J. Daly, A. Palotie, FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944), 508–518 (2023). https://doi.org/10.1038/s41586-022-05473-8
N. Rusk, The UK Biobank. Nat. Methods 15(12), 1001 (2018). https://doi.org/10.1038/s41592-018-0245-2
S. Sanna, N.R. van Zuydam, A. Mahajan, A. Kurilshikov, A. Vich Vila, U. Võsa, Z. Mujagic, A.A.M. Masclee, D. Jonkers, M. Oosting, L.A.B. Joosten, M.G. Netea, L. Franke, A. Zhernakova, J. Fu, C. Wijmenga, M.I. McCarthy, Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51(4), 600–605 (2019). https://doi.org/10.1038/s41588-019-0350-x
J.R. Staley, J. Blackshaw, M.A. Kamat, S. Ellis, P. Surendran, B.B. Sun, D.S. Paul, D. Freitag, S. Burgess, J. Danesh, R. Young, A.S. Butterworth, PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32(20), 3207–3209 (2016). https://doi.org/10.1093/bioinformatics/btw373
Y. Wu, Y. Li, J. Zhu, J. Long, Shared genetics and causality underlying epilepsy and attention-deficit hyperactivity disorder. Psychiatry Res. 316, 114794 (2022). https://doi.org/10.1016/j.psychres.2022.114794
M. Verbanck, C.Y. Chen, B. Neale, R. Do, Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50(5), 693–698 (2018). https://doi.org/10.1038/s41588-018-0099-7
A.C. Fenneman, E. Bruinstroop, M. Nieuwdorp, A.H. van der Spek, A. Boelen, A comprehensive review of thyroid hormone metabolism in the gut and its clinical implications. Thyroid 33(1), 32–44 (2023). https://doi.org/10.1089/thy.2022.0491
Liu Q., Sun W., Zhang H. Interaction of gut microbiota with endocrine homeostasis and thyroid cancer. Cancers 14(11) (2022). https://doi.org/10.3390/cancers14112656
R. John Wallace, Gut microbiology—broad genetic diversity, yet specific metabolic niches. Animal 2(5), 661–8 (2008). https://doi.org/10.1017/s1751731108001687
H. Derakhshani, S.W. Corley, R. Al Jassim, Isolation and characterization of mimosine, 3, 4 DHP and 2, 3 DHP degrading bacteria from a commercial rumen inoculum. J. Basic Microbiol. 56(5), 580–5 (2016). https://doi.org/10.1002/jobm.201500590
S.H. Chang, Y. Choi, Gut dysbiosis in autoimmune diseases: association with mortality. Front. Cell. Infect. Microbiol. 13, 1157918 (2023). https://doi.org/10.3389/fcimb.2023.1157918
M. Alexander, Q.Y. Ang, R.R. Nayak, A.E. Bustion, M. Sandy, B. Zhang, V. Upadhyay, K.S. Pollard, S.V. Lynch, P.J. Turnbaugh, Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe 30(1), 17–30.e9 (2022). https://doi.org/10.1016/j.chom.2021.11.001
J.D. Forbes, C.Y. Chen, N.C. Knox, R.A. Marrie, H. El-Gabalawy, T. de Kievit, M. Alfa, C.N. Bernstein, G. Van Domselaar, A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome 6(1), 221 (2018). https://doi.org/10.1186/s40168-018-0603-4
N. Li, J. Wang, P. Liu, J. Li, C. Xu, Multi-omics reveals that Bifidobacterium breve M-16V may alleviate the immune dysregulation caused by nanopolystyrene. Environ. Int. 163, 107191 (2022). https://doi.org/10.1016/j.envint.2022.107191
B. Zhang, T. Chen, M. Cao, C. Yuan, R.J. Reiter, Z. Zhao, Y. Zhao, L. Chen, W. Fan, X. Wang, X. Zhou, C. Li, Gut microbiota dysbiosis induced by decreasing endogenous melatonin mediates the pathogenesis of Alzheimer’s disease and obesity. Front. Immunol. 13, 900132 (2022). https://doi.org/10.3389/fimmu.2022.900132
X. Zhang, D. Yu, D. Wu, X. Gao, F. Shao, M. Zhao, J. Wang, J. Ma, W. Wang, X. Qin, Y. Chen, P. Xia, S. Wang, Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance. Cell Host Microbe 31(3), 418–432.e8 (2023). https://doi.org/10.1016/j.chom.2023.01.013
S. Just, S. Mondot, J. Ecker, K. Wegner, E. Rath, L. Gau, T. Streidl, G. Hery-Arnaud, S. Schmidt, T.R. Lesker, V. Bieth, A. Dunkel, T. Strowig, T. Hofmann, D. Haller, G. Liebisch, P. Gérard, S. Rohn, P. Lepage, T. Clavel, The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism. Microbiome 6(1), 134 (2018). https://doi.org/10.1186/s40168-018-0510-8
M.T. Sorbara, E.R. Littmann, E. Fontana, T.U. Moody, C.E. Kohout, M. Gjonbalaj, V. Eaton, R. Seok, I.M. Leiner, E.G. Pamer, Functional and genomic variation between human-derived isolates of Lachnospiraceae reveals inter- and intra-species diversity. Cell Host Microbe 28(1), 134–146.e4 (2020). https://doi.org/10.1016/j.chom.2020.05.005
J. Cao, N. Wang, Y. Luo, C. Ma, Z. Chen, C. Chenzhao, F. Zhang, X. Qi, W. Xiong, A cause-effect relationship between Graves’ disease and the gut microbiome contributes to the thyroid-gut axis: a bidirectional two-sample Mendelian randomization study. Front. Immunol. 14, 977587 (2023). https://doi.org/10.3389/fimmu.2023.977587
Wu M.D., Cheng M.J. Undescribed metabolites from an Actinobacteria Acrocarpospora punica and their anti-inflammatory activity. Molecules 27(22) (2022). https://doi.org/10.3390/molecules27227982
Su Y.S., Wu M.D., Chen J.J., Cheng M.J., Kuo Y.H., Chai C.Y., Kwan A.L. Secondary metabolites with anti-inflammatory activities from one Actinobacteria Amycolatopsis Taiwanensis. Molecules 26(19) (2021). https://doi.org/10.3390/molecules26195765
Chen J.J., Lee T.H., Cheng M.J. Secondary metabolites with anti-inflammatory activities from an Actinobacteria Herbidospora daliensis. Molecules 27(6) (2022). https://doi.org/10.3390/molecules27061887
R. Pittayanon, J.T. Lau, Y. Yuan, G.I. Leontiadis, F. Tse, M. Surette, P. Moayyedi, Gut microbiota in patients with irritable bowel syndrome—A systematic review. Gastroenterology 157(1), 97–108 (2019). https://doi.org/10.1053/j.gastro.2019.03.049
Z. Zhuang, N. Li, J. Wang, R. Yang, W. Wang, Z. Liu, T. Huang, GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur. J. Clin. Nutr. 76(7), 1024–1030 (2022). https://doi.org/10.1038/s41430-022-01074-w
A.D. Kjaergaard, E. Marouli, A. Papadopoulou, P. Deloukas, A. Kuś, R. Sterenborg, A. Teumer, S. Burgess, B.O. Åsvold, D.I. Chasman, M. Medici, C. Ellervik, Thyroid function, sex hormones and sexual function: a Mendelian randomization study. Eur. J. Epidemiol. 36(3), 335–344 (2021). https://doi.org/10.1007/s10654-021-00721-z
W. Zhou, B. Brumpton, O. Kabil, J. Gudmundsson, G. Thorleifsson, J. Weinstock, M. Zawistowski, J.B. Nielsen, L. Chaker, M. Medici, A. Teumer, S. Naitza, S. Sanna, U.T. Schultheiss, A. Cappola, J. Karjalainen, M. Kurki, M. Oneka, P. Taylor, L.G. Fritsche, S.E. Graham, B.N. Wolford, W. Overton, H. Rasheed, E.B. Haug, M.E. Gabrielsen, A.H. Skogholt, I. Surakka, G. Davey Smith, A. Pandit, T. Roychowdhury, W.E. Hornsby, J.G. Jonasson, L. Senter, S. Liyanarachchi, M.D. Ringel, L. Xu, L.A. Kiemeney, H. He, R.T. Netea-Maier, J.I. Mayordomo, T.S. Plantinga, J. Hrafnkelsson, H. Hjartarson, E.M. Sturgis, A. Palotie, M. Daly, C.E. Citterio, P. Arvan, C.M. Brummett, M. Boehnke, A. de la Chapelle, K. Stefansson, K. Hveem, C.J. Willer, B.O. Åsvold, GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. Nat. Commun. 11(1), 3981 (2020). https://doi.org/10.1038/s41467-020-17718-z
W. Zhou, B. Brumpton, O. Kabil, J. Gudmundsson, G. Thorleifsson, J. Weinstock, M. Zawistowski, J.B. Nielsen, L. Chaker, M. Medici, A. Teumer, S. Naitza, S. Sanna, U.T. Schultheiss, A. Cappola, J. Karjalainen, M. Kurki, M. Oneka, P. Taylor, L.G. Fritsche, S.E. Graham, B.N. Wolford, W. Overton, H. Rasheed, E.B. Haug, M.E. Gabrielsen, A.H. Skogholt, I. Surakka, G. Davey Smith, A. Pandit, T. Roychowdhury, W.E. Hornsby, J.G. Jonasson, L. Senter, S. Liyanarachchi, M.D. Ringel, L. Xu, L.A. Kiemeney, H. He, R.T. Netea-Maier, J.I. Mayordomo, T.S. Plantinga, J. Hrafnkelsson, H. Hjartarson, E.M. Sturgis, A. Palotie, M. Daly, C.E. Citterio, P. Arvan, C.M. Brummett, M. Boehnke, A. de la Chapelle, K. Stefansson, K. Hveem, C.J. Willer, B.O. Åsvold, Author correction: GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer. Nat. Commun. 12(1), 7354 (2021). https://doi.org/10.1038/s41467-021-27675-w
Acknowledgements
We want to acknowledge all participants of this study and the technical support provided by the Jiangsu University.
Funding
This study was supported by the Guang Ren Foundation Research Project of Affiliated Hospital of Jiangsu University (KRY-YN2022017), the Suzhou Key Clinical Disease Diagnosis and Treatment Technology of Special Project (LCZX202023), and the Suzhou Science and Technology Planning Project (STL2021006).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Zhaoxiang Wang, Menghuan Wu, Ying Pan
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Z., Wu, M., Pan, Y. et al. Causal relationships between gut microbiota and hypothyroidism: a Mendelian randomization study. Endocrine 83, 708–718 (2024). https://doi.org/10.1007/s12020-023-03538-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03538-w